Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)

被引：0
|
作者：
O. Katopodis
J. Souglakos
E. Stathopoulos
A. Christopoulou
E. Kontopodis
A. Kotsakis
K. Kalbakis
N. Kentepozidis
A. Polyzos
D. Hatzidaki
V. Georgoulias
机构：
[1] Hellenic Oncology Research Group (HORG),
来源：
Cancer Chemotherapy and Pharmacology | 2014年 / 74卷
关键词：
Gemcitabine; Oxaliplatin; Erlotinib; Phase II trial; Pancreas;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：333 / 340
页数：7
相关论文
共 50 条
  • [31] Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer
    Carles, J.
    Esteban, E.
    Climent, M.
    Font, A.
    Gonzalez-Larriba, J. L.
    Berrocal, A.
    Garcia-Ribas, I.
    Marfa, X.
    Fabregat, X.
    Albanell, J.
    Bellmunt, J.
    ANNALS OF ONCOLOGY, 2007, 18 (08) : 1359 - 1362
  • [32] Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study
    Stathopoulos, GP
    Syrigos, K
    Polyzos, A
    Fountzilas, G
    Rigatos, SK
    Ziras, N
    Potamiannou, A
    Tsiakopoulos, I
    Androulakis, N
    Aravantinos, G
    Athanasiadis, A
    Papakotoulas, P
    Georgoulias, V
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 224 - 229
  • [33] The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma - A Phase II study of the Hellenic Cooperative Oncology Group
    Bamias, A
    Moulopoulos, LA
    Koutras, A
    Aravantinos, G
    Fountzilas, G
    Pectasides, D
    Kastritis, E
    Gika, D
    Skarlos, D
    Linardou, H
    Kalofonos, HP
    Dimopoulos, MA
    CANCER, 2006, 106 (02) : 297 - 303
  • [34] A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer
    Andrew H. Ko
    Alan P. Venook
    Emily K. Bergsland
    R. Kate Kelley
    W. Michael Korn
    Elizabeth Dito
    Brian Schillinger
    Janet Scott
    Jimmy Hwang
    Margaret A. Tempero
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 1051 - 1057
  • [35] Docetaxel and Intermittent Erlotinib in Patients with Metastatic Non-small Cell Lung Cancer; A Phase II Study From The Hellenic Cooperative Oncology Group
    Karavasilis, Vasilios
    Kosmidis, Paris
    Syrigos, Konstantinos N.
    Mavropoulou, Polyxeni
    Dimopoulos, Meletios A.
    Kotoula, Vassiliki
    Pectasides, Dimitrios
    Boukovinas, Ioannis
    Klouvas, George
    Kalogera-Fountzila, Anna
    Papandreou, Christos N.
    Fountzilas, George
    Briasoulis, Evangelos
    ANTICANCER RESEARCH, 2014, 34 (10) : 5649 - 5655
  • [36] A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer
    Sanghvi, Samrat M.
    Coffman, Alex R.
    Hsueh, Chung-Tsen
    Kang, Joseph
    Park, Annie
    Solomon, Naveenraj L.
    Garberoglio, Carlos A.
    Reeves, Mark E.
    Slater, Jerry D.
    Yang, Gary Y.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, : 1989 - 1996
  • [37] Gemcitabine and cisplatin in the treatment of advanced or metastatic pancreatic cancer
    Heinemann, V
    Wilke, H
    Mergenthaler, HG
    Clemens, M
    König, H
    Illiger, HJ
    Arning, M
    Schalhorn, A
    Possinger, K
    Fink, U
    ANNALS OF ONCOLOGY, 2000, 11 (11) : 1399 - 1403
  • [38] Severe lung and skin toxicity during treatment with gemcitabine and erlotinib for metastatic pancreatic cancer
    Boeck, Stefan
    Hausmann, Andreas
    Reibke, Roland
    Schulz, Christoph
    Heinemann, Volker
    ANTI-CANCER DRUGS, 2007, 18 (09) : 1109 - 1111
  • [39] A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
    Jo, Jung Hyun
    Jung, Dawoon E.
    Lee, Hee Seung
    Park, Soo Been
    Chung, Moon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Cho, Sangsook
    Song, Si Young
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (09) : 1565 - 1577
  • [40] Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study
    Kim, Jung Hoon
    Lee, Sang-Cheol
    Oh, Sung Yong
    Song, Seo-Young
    Lee, Namsu
    Nam, Eun Mi
    Lee, Soonil
    Hwang, In Gyu
    Lee, Hyo Rak
    Lee, Kyu Taek
    Bae, Sang-Byung
    Kim, Han Jo
    Jang, Joung Soon
    Lim, Do Hyoung
    Lee, Hyun Woo
    Kang, Seok Yun
    Kang, Jung Hun
    CANCER COMMUNICATIONS, 2018, 38
12345